Farrell Simon, Pharm. D.

Farrell Simon, Pharm. D.

Chief Commercial OfficeratTrevi Therapeutics· In proxies 2024–2025

Pay in FY2025Trevi Therapeutics stock +203.9% the same year

Farrell Simon, Pharm. D. was paid $1.4M in FY2025 (Dec). Trevi Therapeutics stock rose 203.9% that year.

Pay$100 in the stock at the end of FY23 → $934
Pay is from the Summary Compensation Table of each Trevi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Trevi TherapeuticsPublic company · 2 yr
    • Chief Commercial Officer2024 – Present · 2 yrStock in role +845%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?